Shanghai Shen Lian Biomedical Corporation's high P/S ratio i...
Shanghai Shen Lian Biomedical Corporation's high P/S ratio is alarming considering its recent revenue drop. Shareholders may face a tough time ahead unless the recent medium-term conditions improve.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000014815324d62ed6.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment